Pre-clinical studies of 2'-fluoro-5-[C-11]-methyl-1-beta-D-arabinofuranosyluracil (FMAU): A potential PET indicator of tumor proliferation.

被引：0
|
作者：
Conti, PS
Anderson, JH
Wong, DF
Bading, JR
Alauddin, MM
Ravert, HT
MAtthews, WB
Musachio, JL
Dannals, RF
Scheffel, U
机构：
[1] UNIV SO CALIF,LOS ANGELES,CA 90033
[2] JOHNS HOPKINS MED INST,BALTIMORE,MD 21205
来源：
JOURNAL OF NUCLEAR MEDICINE | 1996年 / 37卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：419 / 419
页数：1
相关论文
共 30 条
  • [1] SYNTHESIS OF 2'-FLUORO-5-[C-11]-METHYL-1-BETA-D-ARABINOFURANOSYLURACIL ([C-11]-FMAU) - A POTENTIAL NUCLEOSIDE ANALOG FOR IN-VIVO STUDY OF CELLULAR PROLIFERATION WITH PET
    CONTI, PS
    ALAUDDIN, MM
    FISSEKIS, JR
    SCHMALL, B
    WATANABE, KA
    NUCLEAR MEDICINE AND BIOLOGY, 1995, 22 (06) : 783 - 789
  • [2] Pharmacokinetics of 2'-fluoro-5-[11C]-methyl-1-β-D-arabinofuranosyluracil ([11C]FMAU) in monkeys.
    Bading, JR
    Alauddin, MM
    Fissekis, JD
    Kirkman, E
    Vail, A
    Conti, PS
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 234P - 234P
  • [3] SYNTHESIS OF 2'-FLUORO-5-[C-11-METHYL]-1-BETA-D-ARABINOFURANOSYLURACIL (C-11-FMAU) FOR USE IN IN-VIVO IMAGING BY POSITRON EMISSION TOMOGRAPHY (PET)
    ALAUDDIN, MM
    FISSEKIS, JR
    CONTI, PS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 45 - NUCL
  • [4] Tumor imaging with 2′-fluoro-5-11C-methyl-1-β-D-arabinofuranosyluracil (11C-FMAU):: Initial clinical studies.
    Conti, PS
    Bading, JR
    Alauddin, MM
    Fissekis, JD
    Berenji, B
    Hayles, S
    Jadvar, H
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 26P - 26P
  • [5] SELECTIVE ALKYLATION SUITABLE FOR LABELING THE ANTIVIRAL AGENT 2'-FLUORO-5-METHYL-1-BETA-D-ARABINOFURANOSYLURACIL(FMAU) WITH C-11 FOR USE IN INVIVO IMAGING
    SUNDOROWU, BM
    SCHMALL, B
    CONTI, PS
    WATANABE, KA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1984, 187 (APR): : 14 - ORGN
  • [6] Pharmacokinetics of the thymidine analog 2′-fluoro-5-[14C]-methyl-1-β-D-arabinofuranosyluracil ([14C]FMAU) in rat prostate tumor cells
    Bading, JR
    Shahinian, AH
    Bathija, P
    Conti, PS
    NUCLEAR MEDICINE AND BIOLOGY, 2000, 27 (04) : 361 - 368
  • [7] Pharmacokinetics and radiation dosimetry of 2′-fluoro-5-11C-methyl-1-β-D-arabinofuranosyluracil (11C-FMAU) in humans.
    Bading, JR
    Alauddin, MM
    Shahinian, AH
    Conti, PS
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 266P - 266P
  • [8] Preliminary clinical imaging trails with the tumor imaging 2′-deoxy-2′-fluoro-5-[11C]-methyl-1-β-D-arabinofuranosyl-uracil (11C-FMAU):: Comparison studies with FDG
    Conti, PS
    Bading, J
    Alauddin, MM
    Fissekis, JD
    Berenji, B
    RADIOLOGY, 2002, 225 : 660 - 660
  • [9] Biodistribution and metabolism of 2'-1-β-D-fluoro-5-methyl-arabinofuranosyluracil (FMAU) in tumor bearing rats.
    Bading, JR
    Shahinian, AH
    Koszalka, GW
    Vail, A
    Conti, PS
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 37P - 37P
  • [10] Pharmacokinetics of the thymidine analog 2′-fluoro-5-methyl-1-β-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats
    Bading, JR
    Shahinian, AH
    Vail, A
    Bathija, P
    Koszalka, GW
    Koda, RT
    Alauddin, MM
    Fissekis, JD
    Conti, PS
    NUCLEAR MEDICINE AND BIOLOGY, 2004, 31 (04) : 407 - 418
123